Best of Obesity Forum: Personalizing Management and Conversations in Obesity Care

This continuing medical education activity is provided by

This activity is supported by educational grants from Lilly and Novo Nordisk, Inc.

Activity Description

This program incorporates didactic presentations covering the patient experience; pharmacological management of obesity, including addressing negative perceptions and rationale for its use; obesity in children and adolescents; considerations for obesity management; obesity as a chronic disease; and initiating weight-loss conversations.

Target Audience

The intended audience for this activity is pharmacists and other healthcare professionals involved in the management of patients with overweight and obesity.

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

• Recognize obesity as a chronic, progressive, yet treatable disease characterized by multifactorial etiology, appetite dysregulation, and significant comorbidities/obesity-related complications.
• Employ motivational interviewing and other approaches to effectively initiate discussions with patients about chronic weight management.
• Identify personal negative weight biases towards people with obesity that may be roadblocks to effective obesity management.
• Incorporate interprofessional coordination of care, patient preferences/perspectives, and shared decision-making regarding evidence-based obesity treatments.
• Discuss the negative perceptions associated with early generation anti-obesity medications (AOMs), improvements in the safety and efficacy profiles of current AOMs, and rationale for their early use in clinical practice.
• Implement the most recent clinical data for medication management of overweight and obesity in children and adolescents.
• Apply the pharmacological management of overweight and obesity based on evidence-based interventions, patient needs, and recent and long-term clinical data including evidence regarding weight regain after cessation of medication.

Course Chair

Robert F. Kushner, MD, MS, FACP, FTOS, DABOM
Professor, Departments of Medicine and Medical Education
Northwestern University Feinberg School of Medicine
Director, Center for Lifestyle Medicine
Northwestern Medicine
Chicago, IL

Faculty

Paul Davidson, PhD
Independent Behavioral Consultant
Boston, MA

Scott Kahan, MD, MPH, FTOS, DABOM
Director, National Center for Weight and Wellness
Johns Hopkins Bloomberg School of Public Health
Washington, DC

Elizabeth Paul, MA
Patient Advocate
Board Member, Obesity Action Coalition
Director of Development, Connections Ministry
Mankato, MN

Donna H. Ryan, MD, FACP, FTOS
Professor Emerita
Pennington Biomedical Research Center
Louisiana State University
Baton Rouge, LA

Edmond P. Wickham III, MD, MPH, DABOM, FAAP
Associate Professor of Internal Medicine and Pediatrics
Division of Endocrinology, Diabetes and Metabolism
Co-Director, Healthy Lifestyles Center
Children’s Hospital of Richmond
Virginia Commonwealth University
Richmond, VA

Planners/Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Jennifer Frederick, PharmD, BCPS

Accreditation Statements

In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

This program is acceptable for 2.25 contact hours of ACPE Continuing Education Credit. The ACPE Universal Program Number is JA0006104-0000-23-033-H01-P, effective 10/31/2023. This is a knowledge-based activity, and there is no fee to attend.

Vindico Medical Education will provide pharmacist credits claimed information directly to the ACPE through CPE Monitor within 30 days. 

How to Participate in This Activity and Obtain CE Credit:

To participate in this activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 5 of the 7 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue a Statement of Continuing Pharmacy Education Credit.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Course Chair and Faculty report the following relevant financial relationship(s)

Paul Davidson, PhD
No relevant financial relationships to disclose.

Scott Kahan, MD, MPH, FTOS, DABOM
Consultant: Gelesis, Lilly, Novo Nordisk, Pfizer, Vivus

Robert F. Kushner, MD, MS, FACP, FTOS, DABOM
Consultant: Altimmune, Boehringer Ingelheim, Lilly, Novo Nordisk, Pfizer, WeightWatchers

Elizabeth Paul, MA
Advisor: Boehringer Ingelheim, Pfizer
Speaker Contracted by Ineligible Company: Boehringer Ingelheim, Lilly

Donna H. Ryan, MD, FACP, FTOS
Advisor: Altimmune, Calibrate, Gila Therapeutics, Lilly, Novo Nordisk, Real Appeal, Wondr Health, Xeno, YSOPIA, Zealand
Consultant: Amgen, IFA Celtic, Scientific Intake, Wondr Health
Speaker Contracted by Ineligible Company: IFA Celtic, Novo Nordisk
Independent Research Contractor: Lilly, Rhythm
Data Safety Monitoring Board: IQVIA
SELECT Steering Committee: Novo Nordisk

Edmond P. Wickham III, MD, MPH, DABOM, FAAP
No relevant financial relationships to disclose

Planners/Reviewers report the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Jennifer Frederick, PharmD, BCPS
No relevant financial relationships to disclose.

Vindico Medical Education Staff

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher.

The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CE Questions?

Contact us at CME@VindicoCME.com